RTX CORPORATION (RTX)
Outperform

RTX: A Blowout Beat-and-Raise Rebuts the 2027 Commercial Fear — Maintaining Outperform as the Thesis Confirms

Published: By A.N. Burrows RTX | Q2 2026 Earnings Analysis

Second note in our RTX coverage. We initiated at Outperform after Q1 (PT $212); this quarter tests whether the defense super-cycle and the Pratt recovery are delivering, and grades the commitments management made on the Q1 call.

Key Takeaways

  • This was the best print in five quarters: adjusted EPS of $1.89 beat the $1.66 Street by ~14%, revenue of $24.71B beat ~$22.9B by ~8%, organic growth hit 16%, and all three segments expanded margin. The stock rose 7.3% to $209.16 on a day the S&P fell 1.2%.
  • The raise was the story. FY26 adjusted sales guidance went up $2.5B to $95–96B, EPS up to $7.10–$7.25 (midpoint +5.5% to $7.18), and free cash flow's low end rose $250M. The organic growth guide jumped three full points to 8–9%, and the new EPS guide sits above where the Street already was.
  • The exact fear that sank the stock 4.4% after Q1 was rebutted head-on: commercial aftermarket accelerated to +18%, management said "customer behaviors remain unchanged," and it raised the aftermarket guide to low double digits. The 2027 commercial worry did not disappear, but it lost its urgency.
  • The defense super-cycle intensified: Raytheon booked $19.9B for a 2.42 book-to-bill, backlog hit a record $289B (up 22%), international bookings doubled year-over-year, and a $1.1 trillion FY27 base budget request (roughly +25%) sits behind it. The framework agreements are still not in backlog.
  • Rating: Maintaining Outperform. The thesis confirmed on every axis and the numbers moved up, so we lift our price target to $230 from $212. But at ~29x the raised FY26 EPS midpoint and near all-time highs, valuation is now the binding constraint; we would not chase the 7% pop and would add on pullbacks rather than strength.

Results vs. Consensus

Metric (Q2 2026, adjusted)ActualConsensusBeat/MissMagnitude
Sales$24.71B~$22.9BBeat+7.8% (~+$1.8B)
Organic sales growth+16%n/aStrongAll 3 channels double-digit ex-OE
Adjusted segment operating profit$3.2Bn/a+18% YoY+40 bps segment margin
Adjusted EPS$1.89$1.66Beat+13.7% (+$0.23)
GAAP EPS (continuing ops)$1.57~$1.35+29% YoYincl. $0.32 adj./restructuring
Free cash flow$2.9Bn/avs. -$72M PYWork-stoppage catch-up + advances

Year-over-Year

Metric (adjusted)Q2 2026Q2 2025YoY
Sales$24.71B$21.58B+14.5% (+16% organic)
Segment operating profit$3.2B~$2.71B+18%
Adjusted net income$2.6B~$2.13B+22%
Adjusted EPS$1.89$1.56+21%
GAAP EPS (cont. ops)$1.57$1.22+29%
Operating margin11.4%9.9%+150 bps
Free cash flow$2.9B-$72M+~$3.0B
Backlog$289B~$237B+22%

Sequential (vs. Q1 2026)

Metric (adjusted)Q2 2026Q1 2026QoQ
Sales$24.71B$22.08B+11.9%
Adjusted EPS$1.89$1.78+6.2%
Segment operating profit$3.2B$2.9B+10.3%
Free cash flow$2.9B$1.3B+$1.6B
Backlog$289B$271B+$18B (+6.6%)
Raytheon book-to-bill2.420.96Step change
Quality of the beat. Even higher quality than Q1. The revenue upside was organic (+16%) and led by the highest-margin channels, with commercial aftermarket up 18% and defense up 16%; the segment operating profit grew 18% with margin expansion in all three segments. Of the $0.40 FY EPS raise, management attributed roughly $0.26 to segment operating profit, so the raise is operating-driven, not a below-the-line dress-up. Free cash flow of $2.9B did benefit from two identifiable timing items, a catch-up from last year's Pratt work stoppage and international advance payments at Raytheon, so H2 cash will not simply run at this rate, but the underlying conversion is real. The one honest caveat: the H2 organic growth guide implies a deceleration to roughly 5% on tough comparisons, so the headline 16% is a first-half peak, not a run-rate.

Assessment

Revenue: An 8% top-line beat on a base this large is a genuine blowout, and the composition could hardly be better: commercial aftermarket +18%, defense +16%, commercial OE +9%. The record $289B backlog with a company-wide order haul of roughly $43B says demand is still comfortably outrunning a quarter that itself grew 16% organically. This is the shape of a mid-cycle acceleration, not a late-cycle peak.

Margins: Operating margin expanded 150 bps year-over-year to 11.4% and segment margin rose 40 bps with all three segments contributing. The standout remains Raytheon at 12.6% (up 100 bps), which management framed as tracking toward its long-stated full potential. Margin expansion during a double-digit volume ramp is the single most bullish structural signal RTX can send, and it sent it again.

EPS: The $1.89 is a clean, operating-led beat, up 21% adjusted and 29% on a GAAP basis. Unlike Q1, where tax and interest carried a visible slice of the growth, Q2's upside was overwhelmingly segment-driven. The FY raise to a $7.18 midpoint, now above the pre-print Street of roughly $6.92, is the number that will pull sell-side models higher.

Segment Performance

SegmentSalesGrowth (rep / org)Adj. Op. ProfitMargin (YoY)Notable
Collins Aerospace$8.2B+8% / +13%$1.4B (+$121M)~17% (+30 bps)Commercial OE +26%
Pratt & Whitney$8.89B+16% / +17%$740M (+$132M)~8.3% (+30 bps)Aftermarket +25%; OE -8% (mix)
Raytheon$8.27B+18% / +18%$1.0B (+$234M)12.6% (+100 bps)Book-to-bill 2.42; backlog $86B

Collins Aerospace

Collins accelerated to 13% organic growth, and crucially the aftermarket detail reversed the one soft spot from Q1. Where mods and upgrades had fallen 3% in Q1, they rose 11% in Q2, alongside parts and repair up 11% and provisioning up 7%; commercial OE surged 26% on narrow-body and wide-body rate increases. Adjusted operating profit rose $121M and margin expanded 30 bps despite an ongoing tariff headwind and heavy, low-margin wide-body OE content flowing through.

"We've always talked about our ability to get back to, call it, 19%, 20% type margins. And we see no reason why when you think about the growth drivers of that business... all of that puts us in a good position to continue to drive these margins higher over the next several years." — Neil Mitchill, CFO

Assessment: The mods-and-upgrades rebound directly rebuts the "canary in the coal mine" reading from Q1, and management laid out a credible bridge to 19–20% margins built on volume absorption plus aggressive structural cost-out. The wide-body ramp dilutes near-term drop-through, but the self-help program is the multi-year margin story to track.

Pratt & Whitney

Pratt grew 17% organically on a 25% surge in commercial aftermarket and 23% military growth, lapping a Q2 2025 that carried a four-week work stoppage. Commercial OE fell 8%, but for the right reason: large commercial engine deliveries were actually up 15% in units, and the sales decline is a deliberate mix choice as Pratt routes scarce material into MRO to keep bringing grounded GTF aircraft back. Adjusted operating profit rose $132M and margin expanded 30 bps.

"The sales decrease was due to mix as... we continue to ensure that we have strong material flow into our MRO shops. As we mentioned, we saw a good decline in GTF AOGs, down 25% in the first half of the year... 1100 output up 43% year-over-year." — Chris Calio, Chairman & CEO

Assessment: The OE decline reads as a negative on the surface and a positive underneath: RTX is choosing higher-margin aftermarket throughput over lower-margin new-engine sales while accelerating the AOG recovery. With GTF aftermarket margins at low double digits and richening, and the full-year Pratt profit guide raised, this is the razor-and-blade model compounding exactly as intended.

Raytheon

Raytheon was again the engine of the quarter, with 18% organic growth and adjusted operating profit up $234M as margin expanded 100 bps to 12.6% on favorable Patriot-heavy mix and productivity. The order book was staggering: $19.9B of bookings for a 2.42 quarterly book-to-bill (1.77 on a rolling-12-month basis), lifting segment backlog to $86B, now 48% international. Awards included over $5B of GEM-T (including the first domestic GEM-T production order in three decades), $1.8B of AMRAAM, $1.1B of AIM-9X and roughly $800M of LTAMDS.

"We're really pleased with the Raytheon performance this year. I mean, the 18% organic sales growth and the 12.6% margin... it is and continues to be really right on track... The framework agreements that we've talked about, they're not even in this backlog today." — Chris Calio, Chairman & CEO

Assessment: This is the segment re-rating the company in real time. Management characterized the base margin as solid and productivity-light (only ~$40M year-to-date), meaning the 12.6% is structural rather than borrowed from favorable timing. With the framework agreements and Golden Dome still outside the backlog, Raytheon's demand runway extends well beyond what even a record order book shows.

Key KPIs

KPIQ2 2026Trend vs. Q1Read
Total backlog$289B+$18B (+6.6%)New record; $170B com / $119B def
Raytheon quarterly book-to-bill2.42vs. 0.96 in Q1Step-change in defense orders
Raytheon rolling 12-mo book-to-bill1.77vs. 1.48Accelerating
Raytheon backlog % international48%+4 pts YoYGlobal demand broadening
PW1100 AOGs-25% YTDvs. -15% at Q1Overhang lifting faster
PW1100 MRO output+40%+ (43%)vs. +23% at Q1Turnaround time -23%
Munitions output (H1)More than 2x YoYAcceleratingCoyote output also 2x+
Free cash flow$2.9Bvs. $1.3B in Q1Aided by timing items

Key Topics & Management Commentary

Overall Management Tone: Confident and forward-leaning, a clear step up from the more measured, almost defensive posture management adopted on the Q1 call when it went out of its way to pre-empt commercial demand worries. This quarter management led with the raise, spoke in terms of a multi-year demand runway rather than one-quarter caution, and repeatedly returned to the framework agreements and international pipeline as upside still to come. The only note of restraint was deliberate conservatism on the H2 comparisons and on commercial aftermarket assumptions, which management chose to hold rather than extrapolate.

1. The Across-the-Board Guidance Raise

The defining event of the quarter was the size and breadth of the raise. Full-year adjusted sales went up $2.5B to $95–96B, the organic growth guide jumped from 5–6% to 8–9%, adjusted EPS rose to $7.10–$7.25 (a $7.18 midpoint, up 5.5%), and even free cash flow's low end moved up $250M. This contrasts sharply with the modest, defense-only $0.10 EPS raise after Q1.

"On the top line, we're raising our full year adjusted sales outlook by $2.5 billion to a new range of $95 billion to $96 billion... This translates to full year RTX organic sales growth of between 8% and 9%, up from our prior range of between 5% and 6%." — Neil Mitchill, CFO

Assessment: A three-point lift to the organic growth guide two quarters into the year is a strong statement of conviction, not a mechanical roll-forward of a Q2 beat. That the new EPS midpoint clears the pre-print Street means consensus has to move up, which is the fundamental fuel behind the 7.3% move.

2. Raytheon's March Toward Full-Potential Margin

Raytheon hit 12.6% margin (up 100 bps) on 18% organic growth, and management was explicit that this is tracking toward the full potential it laid out previously, driven by mature-program mix, a supportive supply chain, and a rising international share.

"We saw about $20 million of favorability from productivity in the second quarter... cumulatively, year-to-date, we're about $40 million, which frankly isn't that significant, which tells me that we've got a good solid base margin in the business in the backlog." — Neil Mitchill, CFO

Assessment: The key tell is that only ~$40M of the year-to-date margin came from productivity favorability, meaning the 12.6% is a structurally higher base rather than a timing benefit. That makes the trajectory durable, and management explicitly flagged the framework agreements as a potential further tailwind on top.

3. Framework Agreements: Still Not in Backlog, Conversion Progressing

The five framework agreements for Tomahawk, AMRAAM and the Standard Missile family remain outside the reported backlog, but management characterized the conversion to definitive contracts as productive and detailed the supply-chain groundwork already underway.

"We continue to engage with the department on turning our framework agreements into definitive agreements... those will have significant demand over the next 10 years to the extent that the budget and the multiyear come home. Those aren't even in our backlog today." — Chris Calio, Chairman & CEO

Assessment: This is unchanged from Q1 in substance but firmer in tone; the conversations have moved forward and RTX is pre-investing in supply chain and second/third sources. The single biggest swing factor is the multi-year budget treatment, which would let suppliers commit to the step-change in rate the agreements imply.

4. International Defense: Demand Doubling

International was a recurring theme, and for good reason: Raytheon booked over $10B of international awards in the first half, more than double year-over-year, with over $7B from Europe, and the segment backlog is now 48% international. NATO allies moving toward 3.5% of GDP and a suite of co-production agreements (AMRAAM, Patriot, Stinger, NASAMS) underpin the runway.

"In the first half of the year, Raytheon booked over $10 billion of international awards, which is up more than 2x year-over-year, including over $7 billion from our European customers." — Chris Calio, Chairman & CEO

Assessment: International demand is arguably the most underappreciated leg of the story because it is additive to both the domestic budget and the framework agreements, and it tends to carry better pricing on mature programs. Co-production deepens relationships while adding the capacity RTX needs to ramp, a rare win-win.

5. The FY27 Defense Budget: A $1.1 Trillion Base Request

Management pointed to bipartisan support for a step-up in 2027 U.S. defense spending, with a base budget request crossing $1.1 trillion (roughly a 25% increase) and meaningful increases for RTX priority programs including Tomahawk, LTAMDS and Standard Missile.

"We're pleased to see that the U.S. base budget request crossing the $1 trillion mark, that's significant. And this, plus the multiyear requests that are in there show the continued demand... for years to come." — Chris Calio, Chairman & CEO

Assessment: A budget of this magnitude, concentrated in munitions and air-and-missile defense, is the macro backdrop that turns the framework agreements from possibility into probability. Even accounting for the usual gap between a request and an enacted budget (and the risk of a continuing resolution), the direction and bipartisan support are unusually clear.

6. GTF and the Powder-Metal Overhang Lifting

The Pratt recovery accelerated: PW1100 AOGs are down 25% year-to-date (versus down 15% at Q1), MRO output rose more than 40% (43%) with a 23% turnaround-time reduction and 14 points heavier work scope. Management reiterated the financial and technical outlook remains on track and set a network goal of consistent 90-day-or-below turnaround across its roughly 15 PW1100 shops.

"PW1100 AOGs are down again sequentially and down 25% year-to-date, and we expect AOGs to keep trending lower throughout the second half of the year. The improvement is driven by MRO output, which was up over 40% year-over-year." — Chris Calio, Chairman & CEO

Assessment: The acceleration from -15% to -25% AOGs in a single quarter is the clearest evidence yet that the 18-month overhang is genuinely lifting, and faster than the sell-side had modeled. Fewer AOGs means fewer customer compensation claims and better 2H margins, a compounding positive.

7. Pratt Commercial OE Down 8%: A Feature, Not a Bug

The 8% decline in Pratt commercial OE drew questions, and management was clear it reflects a deliberate allocation of material toward MRO rather than weak demand, with FY OE now guided down low single digits even as unit deliveries and installs grow.

"Even as we see OE sales down a little bit... it's really about the material allocation, and we're taking up the profit for Pratt. So we still see the margin expansion, not just this year, but we expect that to continue in years thereafter." — Neil Mitchill, CFO

Assessment: Trading lower-margin OE revenue for higher-margin aftermarket throughput while still delivering a record number of engines to Airbus is precisely the mix management RTX should be running. The profit guide going up while OE guide goes down is the proof that this is optimization, not weakness.

8. Commercial Aftermarket Resilience Rebuts the Q1 Fear

The bear thesis that torpedoed the Q1 print was that a soft 2027 commercial cycle would hit the aftermarket. Q2 pushed back directly: aftermarket grew 18% company-wide (25% at Pratt), RPKs are expected to grow in all regions outside the Middle East, retirements remain low, and Collins order behavior was unchanged.

"All indications are from the orders that we saw in the second quarter for Collins that the aftermarket remains strong and our customer behaviors remain unchanged." — Neil Mitchill, CFO

Assessment: Management raised the aftermarket guide to low double digits, the opposite of the Q1 caution, while still choosing not to fully extrapolate. The 2027 risk is not eliminated (it is a lagged variable), but the near-term evidence runs against the bears, which is why the stock reversed its Q1 reaction.

9. Collins Margin Self-Help Toward 19–20%

Beyond volume absorption, Collins is executing structural cost reduction: consolidating operations, shifting hours to best-cost locations, and attacking overhead layered on from years of large acquisitions. Management sees a path back to 19–20% margins, with roughly 40% of the H2 margin step-up coming from cost actions and 60% from volume drop-through.

"The Collins team has really taken on in an aggressive way, structural cost reduction actions... consolidating operations, increasing hours at best cost locations, attacking overhead layers... those are still in the early innings." — Chris Calio, Chairman & CEO

Assessment: This is the most concrete margin-expansion program in the portfolio outside Raytheon, and it is largely self-help rather than market-dependent. If Collins converts even part of the way to 19–20% from ~17%, it adds a second internal margin engine alongside Raytheon.

10. Capital Allocation and the Blue Canyon Divestiture

RTX agreed to sell Raytheon's Blue Canyon Technologies for $620M, continued deleveraging (long-term debt down to $31.86B from $34.29B at year-end), raised the dividend, and reiterated an unchanged capital-allocation framework prioritizing organic investment, dividend and debt reduction. Management signaled no appetite for large M&A.

"There's nothing that we think we really need. We think the portfolio is exceptionally strong. We've got a lot of conviction around the growth trajectory in the portfolio... So really no change in our mind about how we think about capital allocation." — Chris Calio, Chairman & CEO

Assessment: Portfolio pruning plus deleveraging plus a dividend raise is a disciplined use of the improving cash base. The unaddressed piece remains the buyback cadence; with the balance sheet strengthening and FCF rising, capacity for shareholder returns is building even if the timing was left open.

11. Second-Half Deceleration and Tough Comps

Management was transparent that the FY 8–9% organic guide implies roughly 5% growth in H2 versus 13% in H1, driven by specific comparisons: the Pratt work-stoppage catch-up and F135 Lot 18 timing in H2 2025, a Pratt OE mix shift toward installs, and Raytheon material receipts normalizing against a strong prior-year second half.

"In the first half, we saw 13% organic growth. And in the second half, you'll see in our outlook, it implies somewhere in the 5% range at the midpoint of our outlook. So still growing, still really strong, but again, some unique comparisons." — Neil Mitchill, CFO

Assessment: The deceleration is optical rather than fundamental, driven by comp dynamics rather than demand cooling, and management was refreshingly specific about the moving parts. The bear will point to the sell-side's ~4% forward revenue model as the multiple's constraint; we read it as conservatism against a still-record order book.

Guidance & Outlook

FY2026 MetricPrior Guide (post-Q1)New GuideChange
Adjusted sales$92.5B–$93.5B$95.0B–$96.0BRaised $2.5B
Organic sales growth5%–6%8%–9%Raised 3 pts
Adjusted EPS$6.70–$6.90$7.10–$7.25Raised (~+$0.38 mid)
Free cash flow$8.25B–$8.75B$8.5B–$8.75BLow end +$250M
Commercial aftermarket growthHigh single digitsLow double digitsRaised
Raytheon segment OP growth+$275M–$375M+$575M–$650MRaised sharply

The raise was broad and operating-led. Of the $0.40 low-end EPS increase, roughly $0.26 comes from higher segment operating profit (net drop-through, favorable defense mix, productivity, mostly at Raytheon), with the remainder from improved below-the-line items. Every segment's full-year profit guide moved up, and the Raytheon range nearly doubled from post-Q1 levels. The free cash flow raise was more modest because management is intentionally building inventory to support the continued ramp into early 2027, a working-capital headwind that offsets some of the higher profit.

Implied ramp: With $3.67 of adjusted EPS earned in H1, the $7.18 FY midpoint implies roughly $3.51 in H2, consistent with the guided organic deceleration to ~5% on tough comps rather than any margin give-back.

Street at: Consensus FY26 EPS sat around $6.92 into the print; the new $7.18 midpoint is above it, so upward revisions are coming, and the average pre-print price target of roughly $215 will likely rise.

Guidance style: Still conservative where the comps are hard (H2 organic, commercial aftermarket held at low double digits rather than stretched), but confident enough to raise all four headline metrics. This is the RTX pattern of guiding to what it can see and letting the beats accumulate.

Analyst Q&A Highlights

Framework agreements and the budget backdrop

The opening question tied the framework agreements to the budget environment, including the risk of starting the year under a continuing resolution.

Q: "Maybe if you could just give us an update on the latest status with all your framework agreements or the progress that you're making there? And if you could just tie it into... the budget environment, I think everyone's expectations are we'll start the year with the CR and how that would affect things."
— Peter Arment, Baird

A: "We continue to engage with the department on turning our framework agreements into definitive agreements. And that process is ongoing... very, very productive and constructive conversations... don't forget about the international demand, still hugely significant, $10 billion of awards in the first half with 48% of Raytheon's backlog being international."
— Chris Calio, Chairman & CEO

Assessment: Management would not put a date or dollar figure on conversion, but the tone was firmer than Q1 and the pivot to international demand reinforced that the runway does not depend solely on a clean U.S. budget process. The CR risk is acknowledged but framed as a timing, not demand, question.

Free cash flow guide and the H2 slowdown

A recurring line of questioning probed why free cash flow's top end did not rise despite the strong first half, and what drives the implied second-half revenue deceleration.

Q: "On the free cash flow, you didn't raise the top end of the free cash flow guidance. I was wondering if timing was anything to do with that very strong performance in Q2. And then... on the revenue guidance, you are factoring in a slowdown in revenue growth in the second half versus the first half. I was wondering what the key drivers are there."
— Robert Stallard, Vertical Research

A: "We took the bottom end of the range up $250 million to reflect the higher segment operating profit... That's offset a little bit by some working capital headwinds... we're going to be building a little bit of inventory to make sure that we're prepared to deliver the continued ramp... the growth that we see coming through in early 2027."
— Neil Mitchill, CFO

Assessment: The candid answer is that Q2 cash benefited from timing (work-stoppage catch-up, international advances) and that H2 cash funds inventory for the 2027 ramp. That is a high-quality reason to hold the top end, and the reference to "growth coming through in early 2027" is a quiet, bullish forward signal.

Pratt commercial OE down 8%

Analysts pressed on the drivers of the Pratt OE decline and whether it reflected allocation, pricing, or something structural.

Q: "Maybe if we could just tease out the puts and takes in Pratt sales growth for the quarter, aftermarket up 25%, military up 23%, OE down 8%... on the Pratt OE down low single digits now, what's driving that? Is it more allocation to Airbus, pricing, something else driving that headwind?"
— Sheila Kahyaoglu, Jefferies

A: "The large commercial engine deliveries were up in Q2, up 15%... The sales decrease was due to mix as... we continue to ensure that we have strong material flow into our MRO shops... we'll deliver a record number of GTF engines this year."
— Chris Calio, Chairman & CEO

Assessment: The exchange clarified that OE units are up 15% even as OE sales fell, confirming the decline is a mix-and-allocation choice, not lost demand. Management is optimizing the whole engine lifecycle for profit, and the raised Pratt profit guide validates the trade-off.

Raytheon's multi-year margin opportunity

One question asked management to frame the art of the possible on Raytheon margin over the next few years given mix, productivity, and international dynamics.

Q: "I was wondering if you could talk a little bit about Raytheon Defense's margin opportunity over several years... productivity mix foreign versus domestic mature programs versus newer programs. If you could just talk about the evolution there and what do you see as sort of the art of the possible?"
— Gautam Khanna, TD Cowen

A: "The 18% organic sales growth and the 12.6% margin... is and continues to be really right on track... these are mature programs... 48% of Raytheon's backlog is international right now on these mature programs, and that also helps drive a little bit better pricing and productivity."
— Chris Calio, Chairman & CEO

Assessment: Management reaffirmed the "full potential" framing without capping it, and the CFO's point that productivity contributed only ~$40M year-to-date is the key: the margin is a structural base, not a timing spike. The framework agreements were explicitly flagged as potential upside on top.

The international defense opportunity, sized

An analyst asked management to consolidate the scattered international commentary into one picture of how the opportunity flows through the numbers.

Q: "I thought I heard you guys say international bookings were up 2x year-over-year. It seems like there's a huge opportunity out there internationally that may not be kind of fully appreciated. And even when these framework agreements come through, there might be international demand on top of that."
— John Godyn, Citi

A: "You're exactly right... you know what's going on with our NATO allies driving their budgets to that 3.5%... 48% of our backlog is international... those co-production agreements in Europe... continuing to grow the industrial base there not only strengthens the relationships, but also continues to add very capable sources... and adds capacity."
— Chris Calio, Chairman & CEO

Assessment: Management effectively endorsed the premise that international is under-appreciated and additive to both the domestic budget and the framework agreements. The co-production angle is the subtle point: it converts a demand tailwind into a capacity solution, addressing the ramp's binding constraint.

Collins margin path and the pace of realization

A question dug into how quickly Collins can realize its margin opportunity and how much is self-help versus mix.

Q: "There's still a significant margin opportunity at Collins. And maybe if you could talk a little bit about the pace of kind of realizing that opportunity and what's in front of us as we think about both the things that you guys can do from a self-help perspective and then also maybe some of the headwinds that might emerge from a mix perspective?"
— Seth Seifman, JPMorgan

A: "About 60% of that step-up is going to come from drop-through on the higher volume... And the rest, 40% of that is going to come from cost reduction actions. Collins has taken on some really significant structural changes to their business... we've always talked about our ability to get back to, call it, 19%, 20% type margins."
— Neil Mitchill, CFO

Assessment: The 60/40 volume/cost split gives a rare, quantified bridge for the H2 margin step-up, and the reaffirmed 19–20% target frames the multi-year upside. Wide-body OE mix is the offsetting headwind, but the self-help is within management's control, which we weight more heavily.

Shape of the missile-demand trajectory

A pointed question asked how the surging tactical-missile demand, layered with Golden Dome, export orders, and the Iran conflict, translates into an achievable production trajectory given the investment required.

Q: "You are already really pushing for higher production rates over the next 3 years or so... How do you see this higher demand today in terms of what the shape of that trajectory can look like given the efforts you would have to invest to bring the rate up?"
— Douglas Harned, Bernstein

A: "All of this... is going to be predicated on the supply chain... The biggest part of this is going to be the multiyear nature on some of these framework agreements. If you can go out and give a supplier or a set of suppliers a 7-year firm order, they will lean forward. They will make the investment... that, to me, can be the single biggest game changer."
— Chris Calio, Chairman & CEO

Assessment: Management was honest that the trajectory is supply-chain-gated, not demand-gated, and identified multi-year firm orders as the mechanism to unlock the next rate step. This reinforces that the framework agreements are less about incremental backlog and more about enabling the entire supply base to invest ahead of demand.

What They're NOT Saying

  1. No firm framework-agreement value or timeline: Two quarters in, the agreements are still described qualitatively ("significant demand over 10 years") with no contract value, unit count, or signing date. The upside is real but remains unquantified and unbooked.
  2. Buyback cadence still unaddressed: Management detailed dividend, deleveraging, and organic investment but again did not commit to a timeline for resuming or sizing share repurchases, despite a visibly strengthening balance sheet and rising cash.
  3. Free cash flow top end held: Sales, EPS, and the FCF floor all rose, but the FCF ceiling did not. The inventory build for the 2027 ramp is the stated reason, but it means the cash conversion story is being deferred, not accelerated.
  4. Tariff quantification stayed vague: Collins still carries a tariff headwind "this year," but management did not put a full-year dollar figure on the net tariff impact, leaving a circulated (and company-unverified) estimate to fill the vacuum.
  5. Airbus volume specifics deferred: Management confirmed a record number of GTF deliveries and no change to full-year installs, but the longer-term volume path and the NGSA business-model negotiations were kept at the level of principle rather than commitment.
  6. H2 aftermarket assumptions held, not raised: Despite an 18% aftermarket quarter, Collins aftermarket guidance was deliberately kept prudent "as we continue to monitor the macro," a quiet acknowledgment that the 2027 commercial question is not fully closed.

Market Reaction

  • Pre-print setup: RTX closed at $194.88 on July 22, up 6.3% YTD, up 24.5% over the trailing twelve months, and up 4.6% over the trailing 30 days, having recovered from the post-Q1 selloff and pressing toward the top of its 52-week closing range of $149.17–$212.16.
  • Reaction (same session, before-open reporter): Shares rose 7.3% to close at $209.16 on July 23, gapping up roughly 5% at the open and building through the day. Volume ran about 2.0x the 30-day average (9.9M vs. 4.9M), a decisive move on heavy participation. The S&P 500 fell 1.2% the same session, so RTX outperformed the tape by more than 8 points.
  • Peer read-through: Lockheed Martin also reported a beat-and-raise in the same window, and the sector tone on defense demand was constructive, reinforcing that this was a genuine fundamental move rather than a company-specific squeeze.

Where Q1 was a clean beat punished for what might go wrong in 2027, Q2 was a bigger beat rewarded for what is going right now. The market got three things it wanted: direct evidence the commercial aftermarket is not cracking, a defense order book that stepped up to a 2.42 book-to-bill, and a raise large enough to pull consensus higher rather than merely validate it. The one-day reversal of the Q1 reaction, up 7.3% on a down-market day, is the clearest possible confirmation that the Q1 selloff was sentiment, not substance.

Street Perspective

Debate: Is the 2027 commercial worry resolved or just deferred?

Bull view: Q2 settled it: aftermarket accelerated to 18%, customer behaviors are unchanged, RPKs grow everywhere outside the Middle East, and the guide was raised. The young V2500 and GTF fleets make the aftermarket fleet-health driven, not discretionary.

Bear view: Aftermarket lags travel by several quarters, so a soft 2026 travel backdrop still shows up in 2027; management pointedly held Collins aftermarket assumptions rather than raising them, and the sell-side still models ~4% forward revenue growth.

Our take: The near-term evidence clearly favors the bulls and de-risks the pillar that sank the Q1 print. We would not declare the lagged risk dead, but we would no longer treat it as the dominant swing factor; the burden of proof has shifted to the bears.

Debate: Does the framework-agreement optionality justify the premium?

Bull view: A decade of munitions demand, a $1.1T FY27 budget, doubling international orders, and a 2.42 book-to-bill are not in numbers or the multiple; when the agreements convert, 2027–2028 estimates step up and the current multiple compresses quickly.

Bear view: The agreements remain unsigned and unquantified two quarters running; paying ~29x forward for optionality that depends on budget mechanics and supply-chain execution is a lot to underwrite, especially near all-time highs.

Our take: The optionality is genuine and increasingly probable given the budget backdrop, but it is not yet bankable. We give RTX credit for it in a higher target while keeping conviction measured precisely because it is not yet booked.

Debate: Has the stock gotten ahead of itself at ~29x?

Bull view: Estimates are moving up, the raise cleared consensus, and RTX still trades at a discount to GE Aerospace with a stronger defense mix and a multi-year, non-cyclical demand backdrop; quality compounders in a super-cycle earn premium multiples.

Bear view: At ~29x the FY26 midpoint and near all-time highs after a 7% pop and a 12%+ run off the Q1 lows, the easy money is made; the H2 deceleration and ~4% forward revenue model leave little room for multiple expansion.

Our take: This is the crux and the reason we hold conviction at prior levels rather than raising it. We stay Outperform on the strength and durability of the fundamentals and the unpriced optionality, but valuation is now the binding constraint; we would add on pullbacks, not chase the pop.

Model Update Needed

ItemPrior Frame (post-Q1)Suggested ChangeReason
FY26 adj. sales$92.5–93.5B$95.5B (new mid)Adopt raised guide; +3 pts organic
FY26 adj. EPS$6.80–6.90$7.18–7.25Raise + beat; lean to/above midpoint
Raytheon segment margin~12%~12.5%+ (mid-12s H2)+100 bps Q2; structural base
Commercial aftermarket growthHigh singleLow double digits+18% Q2; guide raised
FY26 FCF$8.5B mid$8.6B midLow end raised; inventory build offsets
2027 EPS (framework/Golden Dome)Upside scenario~$8.20 base + optionalityRamp + international + budget

Valuation impact: On the raised numbers we lift our 12-month price target to $230 from $212, roughly 28x a 2027 EPS estimate of ~$8.20 (and ~32x the FY26 midpoint, a premium we justify by the super-cycle and unpriced framework optionality). From the $209.16 reaction close, that implies roughly +10% price upside plus a dividend of roughly 1.4%, a low-to-mid-teens total return that keeps RTX an Outperform. The asymmetry now skews toward framework-agreement conversion and the FY27 budget on the upside, against a full multiple and the H2 deceleration on the downside.

Thesis Scorecard Post-Earnings

Thesis PointStatusNotes (vs. Q1 standing thesis)
Bull #1: Defense super-cycle drives multi-year growth and marginConfirmed (stronger)Raytheon +18% organic, +100 bps to 12.6%, 2.42 book-to-bill, $289B backlog, $1.1T FY27 budget; international 2x
Bull #2: Pratt/GTF recovery de-risks the storyConfirmed (stronger)AOGs -25% YTD (vs. -15% at Q1), MRO output +43%, Advantage deliveries to Airbus started
Bull #3: Record backlog underpins visibilityConfirmed$289B (+22% YoY, +6% QoQ), $43B new awards; framework agreements still additive
Bear #1: Commercial aftermarket cyclicality (2027)Challenged (de-risked)Aftermarket +18%, guide raised to low double; "customer behaviors unchanged." Lagged risk remains but weaker
Bear #2: Full valuation limits upsideConfirmed (worse)~29x FY26 mid post-pop, near all-time highs; now the binding constraint
Bear #3: Cash intensity of the rampNeutral / watchFCF floor raised, but top end held for 2027 inventory build; working-capital headwind flagged

Overall: The thesis strengthened materially. Every bull pillar advanced, the primary bear point (2027 commercial) was directly challenged and weakened, and management delivered on the Q1 "commitments to watch": the July guide revisit arrived as a large raise, AOGs fell further, GTF Advantage began deliveries, and FCF tracked higher. The offset is that valuation, the one bear point that got worse, is now the dominant constraint.

Action: Maintain Outperform; raise PT to $230. We would use pullbacks to add rather than chase the 7.3% pop, and we watch framework-agreement conversion, the FY27 budget process, and any first sign of commercial aftermarket softening as the next set of catalysts.

Independence Disclosure As of the publication date, the author holds no position in RTX and has no plans to initiate any position in RTX within the next 72 hours. Aardvark Labs Capital Research maintains a firm-wide policy of not trading any security we cover. No compensation has been received from RTX Corporation or any affiliated party for this research.